Vycor Medical Inc
VYCO· OTC
Filed Nov 13, 2015 · 10-Q · 44 days after period end · 0001354488-15-005000
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $242.86K | $334.34K | $321.63K | $220.12K |
| Net Income | -$506.79K | -$1.28M | -$506.91K | -$792.11K |
| EPS Diluted | -$0.05 | -$0.12 | -$0.08 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 13, 2015 · 44 d after period end